Pages that link to "Q41985981"

The following pages link to Local intracoronary infusions of bradykinin profoundly reduce the severity of ischaemia-induced arrhythmias in anaesthetized dogs (Q41985981):

Displaying 44 items.

• The antiarrhythmic effects of ischaemic preconditioning in anaesthetized dogs are prevented by atropine; role of changes in baroreceptor reflex sensitivity (Q28344843) (← links)
• Interaction of bradykinin with angiotensin, prostacyclin, and nitric oxide in myocardial preservation (Q33692456) (← links)
• Ischemic preconditioning: from basic mechanisms to clinical applications (Q33959657) (← links)
• The kallikrein-kininogen-kinin system: lessons from the quantification of endogenous kinins. (Q34126239) (← links)
• Role of bradykinin in preconditioning and protection of the ischaemic myocardium (Q34542200) (← links)
• Attenuation of the antiarrhythmic effects of ischaemic preconditioning by blockade of bradykinin B2 receptors (Q34793682) (← links)
• B1 receptor involvement in the effect of bradykinin on venular endothelial cell proliferation and potentiation of FGF-2 effects (Q35027769) (← links)
• The effects of Z13752A, a combined ACE/NEP inhibitor, on responses to coronary artery occlusion; a primary protective role for bradykinin (Q35041955) (← links)
• Bradykinin receptors as a therapeutic target (Q35095166) (← links)
• Delineation of a region in the B2 bradykinin receptor that is essential for high-affinity agonist binding (Q35232919) (← links)
• Does the Kinin System Mediate in Cardiovascular Abnormalities? An Overview (Q35556530) (← links)
• Antiarrhythmic drug research (Q35566609) (← links)
• Preconditioning of the ischaemic myocardium; involvement of the L-arginine nitric oxide pathway (Q35871082) (← links)
• Ischemia/reperfusion injury: a review in relation to free tissue transfers (Q35892339) (← links)
• Prevention by an inhibitor of the l‐arginine‐nitric oxide pathway of the antiarrhythmic effects of bradykinin in anaesthetized dogs (Q36330361) (← links)
• Beneficial Effects of Bradykinin on Myocardial Energy Metabolism and Infarct Size (Q36882195) (← links)
• Occult cardiotoxicity--toxic effects on cardiac ischemic tolerance (Q37522854) (← links)
• There is more to life than revascularization: therapeutic targeting of myocardial ischemia/reperfusion injury (Q37774394) (← links)
• The kinin system in hypertensive pathophysiology (Q38004868) (← links)
• Genetic manipulation and genetic variation of the kallikrein-kinin system: impact on cardiovascular and renal diseases. (Q38240527) (← links)
• Salmeterol. (Q40473337) (← links)
• Bradykinin as an endogenous myocardial protective substance with particular reference to ischemic preconditioning--a brief review of the evidence (Q41143385) (← links)
• Bradykinin and Endothelial-Cardiac Myocyte Interactions in Ischemic Preconditioning (Q41592381) (← links)
• Role of kinins in the endothelial protective effect of ischaemic preconditioning (Q41821889) (← links)
• A common mechanism in the protective effects of preconditioning, cardiac pacing and physical exercise against ischemia and reperfusion-induced arrhythmias. (Q41823968) (← links)
• The local intracoronary administration of methylene blue prevents the pronounced antiarrhythmic effect of ischaemic preconditioning (Q42715333) (← links)
• Evaluation of tissue kallikrein activity on survival time after acute coronary artery ligation in hypertensive rats (Q44363849) (← links)
• Myocardial protection with enalaprilat in patients unresponsive to ischemic preconditioning during percutaneous coronary intervention (Q46194797) (← links)
• The anti-inflammatory effect of bradykinin preconditioning in coronary artery bypass grafting (bradykinin and preconditioning). (Q46495944) (← links)
• Captopril potentiates the myocardial infarct size-limiting effect of ischemic preconditioning through bradykinin B2 receptor activation (Q47321568) (← links)
• Do angiotensin converting enzyme inhibitors limit myocardial infarct size? (Q47392736) (← links)
• Participation of angiotensin II and bradykinin in contractile function in dog stunned myocardium (Q51433901) (← links)
• Attenuation of Epinephrine-Induced Dysrhythmias by Bradykinin: Role of Nitric Oxide and Prostaglandins (Q51537226) (← links)
• Suppression of reperfusion arrhythmia by ischemic preconditioning in the rat: is it mediated by the adenosine receptor, prostaglandin, or bradykinin receptor? (Q51605468) (← links)
• Upregulation of the cardiac bradykinin B2 receptors after myocardial infarction. (Q52975230) (← links)
• Detrimental implication of B1 receptors in myocardial ischemia: evidence from pharmacological blockade and gene knockout mice (Q56963610) (← links)
• Bradykinin Preconditions Postischemic Arterial Endothelial Function in Humans (Q58471477) (← links)
• Role of Bradykinin in Protection of Ischemic Preconditioning in Rabbit Hearts (Q71974392) (← links)
• Modification by bradykinin B2 receptor blockade of protection by pacing against ischaemia-induced arrhythmias (Q73467174) (← links)
• Effect of bradykinin B2-receptor antagonism on post-ischemic coronary reperfusion (Q73521978) (← links)
• Inhibition of Both Aminopeptidase P and Angiotensin-Converting Enzyme Prevents Bradykinin Degradation in the Rat Coronary Circulation (Q73617652) (← links)
• Involvement of the endogenous nitric oxide signalling system in bradykinin receptor activation in rat submandibular salivary gland (Q73930211) (← links)
• Effect of bradykinin and its antagonist on survival time after coronary artery occlusion in rats (Q78238990) (← links)
• Bradykinin-induced preconditioning in patients undergoing coronary angioplasty (Q78251152) (← links)